Self-directed peptide use can also be risky for patients taking multiple medications, patients with liver or kidney concerns, people with bleeding disorders, and anyone who has experienced unusual reactions to injectable products
Over the past 20 years, dozens of preclinical studies (in animals and cells, not humans) have shown potentially promising data suggesting the peptide can fight inflammation and promote protein synthesis and angiogenesisthe fancy scientific term for new blood vessel production
The peptide's intellectual property environment currently favours creators, but patents will expire in the late 2030s, which will make it easier for generic manufacturers to make the drug
Dilution itself doesn't degrade the peptide
Use controlled storage, clean research handling, and document workflows carefully